{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:51:53Z","timestamp":1793379113342,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-11-BSV1-0022"],"award-info":[{"award-number":["ANR-11-BSV1-0022"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"crossref","award":["ANR-15-CE18-0032"],"award-info":[{"award-number":["ANR-15-CE18-0032"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"Fondation de la Recherche M\u00e9dicale","doi-asserted-by":"crossref","award":["DVS20131228894"],"award-info":[{"award-number":["DVS20131228894"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Economy, Industry and Competitiveness","award":["FEDER-MAT 2013\u201343127R"],"award-info":[{"award-number":["FEDER-MAT 2013\u201343127R"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RETICS-FEDER RD12\/0034"],"award-info":[{"award-number":["RETICS-FEDER RD12\/0034"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD 16\/0008"],"award-info":[{"award-number":["RD 16\/0008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Complutense Research Group","award":["UCM 920415"],"award-info":[{"award-number":["UCM 920415"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jconrel.2017.09.029","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T19:45:41Z","timestamp":1506109541000},"page":"187-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site"],"prefix":"10.1016","volume":"266","author":[{"given":"Min","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Rodr\u00edguez-Villagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kowalczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Le Normand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Berdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinath","family":"Levy-Boukris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikram","family":"El Zaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bravo-Osuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene T.","family":"Molina-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Herrero-Vanrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0625.2009.01011.x","article-title":"The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?","volume":"19","author":"Farman","year":"2010","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MNH.0b013e32834fb25b","article-title":"Extrarenal effects of aldosterone","volume":"21","author":"Nguyen Dinh Cat","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2013","journal-title":"J. Vasc. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2017.09.029_bb0020","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/1440-1681.12157","article-title":"Vascular effects of aldosterone: sorting out the receptors and the ligands","volume":"40","author":"Feldman","year":"2013","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jconrel.2017.09.029_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IBPC.S13783","article-title":"Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine","volume":"6","author":"Funder","year":"2013","journal-title":"Integr. Blood Press Control"},{"issue":"2\u20135","key":"10.1016\/j.jconrel.2017.09.029_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"14","key":"10.1016\/j.jconrel.2017.09.029_bb0040","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2017.09.029_bb0045","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1096\/fj.09-154344","article-title":"The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells","volume":"24","author":"Zhao","year":"2010","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.jconrel.2017.09.029_bb0050","doi-asserted-by":"crossref","first-page":"e49036","DOI":"10.1371\/journal.pone.0049036","article-title":"The aldosterone-mineralocorticoid receptor pathway exerts anti-inflammatory effects in endotoxin-induced uveitis","volume":"7","author":"Bousquet","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jconrel.2017.09.029_bb0055","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.jconrel.2017.09.029_bb0060","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00009-1","article-title":"Receptor-mediated adrenocorticoid hormone signaling in ocular tissues","volume":"65","author":"Mirshahi","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.029_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.108.176008","article-title":"Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology","volume":"104","author":"Wilkinson-Berka","year":"2009","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.jconrel.2017.09.029_bb0070","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1167\/iovs.11-7675","article-title":"Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina","volume":"52","author":"Zhao","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2017.09.029_bb0075","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","article-title":"Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study","volume":"33","author":"Bousquet","year":"2013","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.jconrel.2017.09.029_bb0080","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","article-title":"Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study","volume":"35","author":"Bousquet","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2017.09.029_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"3","key":"10.1016\/j.jconrel.2017.09.029_bb0095","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.106.105668","article-title":"Induction of rat intestinal P-glycoprotein by spironolactone and its effect on absorption of orally administered digoxin","volume":"318","author":"Ghanem","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.09.029_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmology","volume":"211","author":"Andres-Guerrero","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2017.09.029_bb0105","first-page":"203","article-title":"Biodegradable microspheres for intraocular drug administration","volume":"76","author":"Herrero Vanrell","year":"2001","journal-title":"Arch. Soc. Esp. Oftalmol."},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.029_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery","volume":"52","author":"Herrero-Vanrell","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.029_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623307310955","article-title":"Safety evaluation of ocular drug delivery formulations: techniques and practical considerations","volume":"36","author":"Short","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2017.09.029_bb0120","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2147\/IJN.S64100","article-title":"Safety evaluation of poly(lactic-co-glycolic acid)\/poly(lactic-acid) microspheres through intravitreal injection in rabbits","volume":"9","author":"Rong","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2017.09.029_bb0125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archopthalmol.2011.2627","article-title":"Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study","volume":"130","author":"Kim","year":"2012","journal-title":"Arch. Ophthalmol."},{"issue":"8","key":"10.1016\/j.jconrel.2017.09.029_bb0130","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/02713683.2011.585734","article-title":"Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation","volume":"36","author":"Maldonado","year":"2011","journal-title":"Curr. Eye Res."},{"issue":"10","key":"10.1016\/j.jconrel.2017.09.029_bb0135","doi-asserted-by":"crossref","first-page":"e7507","DOI":"10.1371\/journal.pone.0007507","article-title":"Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography","volume":"4","author":"Fischer","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2017.09.029_bb0140","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/HYPERTENSIONAHA.111.187872","article-title":"Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system","volume":"59","author":"Latouche","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.029_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","article-title":"Neutrophil gelatinase-associated lipocalin, a novel mineralocorticoid biotarget, mediates vascular profibrotic effects of mineralocorticoids","volume":"66","author":"Tarjus","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.029_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/pr.115.011106","article-title":"Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology","volume":"68","author":"Jaisser","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.jconrel.2017.09.029_bb0155","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/IAE.0000000000001303","article-title":"Mineralocorticoid receptor antagonist treatment in bilateral chronic central serous chorioretinopathy: a comparative study of exudative and nonexudative fellow eyes","volume":"37","author":"Gergely","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2017.09.029_bb0160","article-title":"Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy","author":"Pichi","year":"2016","journal-title":"Int. Ophthalmol."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0165","first-page":"310","article-title":"Oral eplerenone for the management of chronic central serous chorioretinopathy","volume":"8","author":"Singh","year":"2015","journal-title":"Int. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1773-2247(13)50016-5","article-title":"Nano and microtechnologies for ophthalmic administration, an overview","volume":"23","author":"Herrero Vanrell","year":"2013","journal-title":"Drug Del. Sci. Tech."},{"issue":"2","key":"10.1016\/j.jconrel.2017.09.029_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone","volume":"89","author":"Barcia","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.jconrel.2017.09.029_bb0180","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2017.09.029_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNF\/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure","volume":"156","author":"Checa-Casalengua","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.09.029_bb0190","first-page":"1783","article-title":"Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2017.09.029_bb0195","first-page":"1002","article-title":"Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1\/rd1 mouse","volume":"11","author":"Andrieu-Soler","year":"2005","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2017.09.029_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.preteyeres.2014.04.002","article-title":"The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies","volume":"42","author":"Herrero-Vanrell","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.jconrel.2017.09.029_bb0205","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.03-0600","article-title":"Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model","volume":"44","author":"Saishin","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2017.09.029_bb0210","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biomaterials.2010.09.063","article-title":"Robust cell integration from co-transplantation of biodegradable MMP2-PLGA microspheres with retinal progenitor cells","volume":"32","author":"Yao","year":"2011","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jconrel.2017.09.029_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12325-011-0019-z","article-title":"The dexamethasone drug delivery system: indications and evidence","volume":"28","author":"London","year":"2011","journal-title":"Adv. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2017.09.029_bb0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/02713689508995797","article-title":"Biodegradation and tissue reaction to intravitreous biodegradable poly(d,l-lactic-co-glycolic)acid microspheres","volume":"14","author":"Giordano","year":"1995","journal-title":"Curr. Eye Res."},{"issue":"12","key":"10.1016\/j.jconrel.2017.09.029_bb0225","first-page":"675","article-title":"Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema","volume":"81","author":"Cardillo","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917308623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:19:25Z","timestamp":1589775565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917308623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":45,"alternative-id":["S0168365917308623"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}